Share
News
1 - 1 of 1 news items
-
14 February 2011 /Product information
Gadolinium-containing MRI contrast agents and risk of nephrogenic systemic fibrosis (NSF)
Following a recent European review, the summaries of product characteristics for gadolinium-containing products are to be updated and harmonised, so that the information is the same throughout the EU.
